Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Adelis Equity Partners closes €1.6bn fourth fund amid strong investor demand
Adelis Equity Partners closes €1.6bn fourth fund amid strong investor demand Adelis Equity Partners completed the final close of its oversubscribed fourth fund, Adelis Fund IV, securing €1.5bn in external capital commitments. With Adelis employees committing an...
CVC serves up $1bn bid for Miami and Madrid Open in tennis power play
CVC serves up $1bn bid for Miami and Madrid Open in tennis power play CVC Capital Partners submitted a $1bn bid to acquire a portfolio of tennis assets, including the Miami Open and Madrid Open, two of the most prestigious tournaments in professional tennis. The sale...
Carlyle eyes up to $5bn in exits as IPO market gains momentum
Carlyle eyes up to $5bn in exits as IPO market gains momentum Carlyle Group is ramping up its exit strategy, targeting up to $5bn in asset sales this year through IPOs and divestments, in line with its 2024 performance. The private equity giant anticipates a...